日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Thrombin generation to predict breakthrough bleeding in patients with acquired hemophilia A under emicizumab prophylaxis

凝血酶生成用于预测接受艾美赛珠单抗预防治疗的获得性血友病A患者的突破性出血

Pelzer, Fabius J; Ertekin, Ella I; Oleshko, Olga; Klingberg, Annika; Knöbl, Paul; Pfrepper, Christian; Greil, Richard; Oldenburg, Johannes; Sachs, Ulrich J; Miesbach, Wolfgang; Trautmann-Grill, Karolin; Holstein, Katharina; Eichler, Hermann; Möhnle, Patrick; Hart, Christina; Klamroth, Robert; Tiede, Andreas; Werwitzke, Sonja

Response to hemophilia B gene therapy based on adenoassociated virus serotype 5 antibody status

基于腺相关病毒5型抗体状态的B型血友病基因治疗反应

Miesbach, Wolfgang; Srivastava, Alok

An analysis of attitudes toward gene therapy in people with severe hemophilia in Germany, a survey-based cross-sectional study

一项基于调查的横断面研究:分析德国重度血友病患者对基因治疗的态度

Babayeva, Svetlana; Peyvandi, Aida; Schepperle, Christian; Auerswald, Günter; Rauchfuss, Steffen; Peyvandi, Flora; Cutica, Ilaria; Miesbach, Wolfgang

Health-Related Quality of Life in Adult Patients With von Willebrand Disease From Germany: Results of the WIL-QoL Study

德国成人血管性血友病患者的健康相关生活质量:WIL-QoL 研究结果

von Mackensen, Sylvia; Moorthi, Carolin; Fischer, Ronald; Halimeh, Susan; Heller, Christine; Miesbach, Wolfgang; Schilling, Freimut H; Wermes, Cornelia; Auerswald, Guenter

Five-Year Experience of Haemophilia Centre Certification Performed by the German, Austrian and Swiss Society for Thrombosis and Haemostasis Research

德国、奥地利和瑞士血栓与止血研究学会开展的血友病中心认证五年经验

Eichler, Hermann; Bönigk, Hagen; Halimeh, Susan; Hart, Christina; Hörner, Judith; Klamroth, Robert; Knöfler, Ralf; Königs, Christoph; Lang, Thomas; Langer, Florian; Miesbach, Wolfgang; Oldenburg, Johannes; Oral, Ramona; Olivieri, Martin; Pfrepper, Christian; Pilch, Jan; Scholz, Ute; Streif, Werner; Albisetti, Manuela

Reply to a letter from Miesbach and Srivastava: response to hemophilia B gene therapy based on adeno-associated virus serotype 5 antibody status

回复 Miesbach 和 Srivastava 的来信:基于腺相关病毒 5 型抗体状态的 B 型血友病基因治疗的回应

Darius, Harald; Grothues, Jens; Haas, Sylvia; Heinemann, Markus; Klamroth, Robert; Miesbach, Wolfgang; Klamroth, Robert; Monahan, Paul E; Le Quellec, Sandra

Clinical perspective: Advancing hemophilia treatment through gene therapy approaches

临床视角:通过基因治疗方法推进血友病治疗

Thornburg, Courtney D; Pipe, Steve W; Cantore, Alessio; Unzu, Carmen; Jones, Micheala; Miesbach, Wolfgang A

Cost-effectiveness of Voncento prophylaxis vs on-demand treatment in von Willebrand disease in the United Kingdom

在英国,Voncento预防性治疗与按需治疗在血管性血友病中的成本效益分析

Wilson, Michele; Castaman, Giancarlo; Thomas, Will; Millar, Carolyn; Escolar, Ginés; Miesbach, Wolfgang; McDade, Cheryl; Tomic, Radovan; Yan, Songkai

Completion of phase 2b trial of etranacogene dezaparvovec gene therapy in patients with hemophilia B over 5 years

针对B型血友病患者的etranacogene dezaparvovec基因疗法的2b期试验已完成5年

von Drygalski, Annette; Gomez, Esteban; Giermasz, Adam; Castaman, Giancarlo; Key, Nigel S; Lattimore, Susan U; Leebeek, Frank W G; Miesbach, Wolfgang A; Recht, Michael; Monahan, Paul E; Le Quellec, Sandra; Pipe, Steven W

Sustained survival benefit of emicizumab and postponed immunosuppression in acquired hemophilia A

在获得性血友病A患者中,艾美赛珠单抗治疗和延迟免疫抑制可带来持续的生存获益

Schimansky, Inga M; Dobbelstein, Christiane; Klamroth, Robert; Hart, Christina; Sachs, Ulrich J; Greil, Richard; Knöbl, Paul; Oldenburg, Johannes; Miesbach, Wolfgang; Pfrepper, Christian; Trautmann-Grill, Karolin; Möhnle, Patrick; Holstein, Katharina; Eichler, Hermann; Werwitzke, Sonja; Tiede, Andreas